Aduhelm 170 mg Injection
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Aduhelm 170 mg Injection contains aducanumab, a monoclonal antibody. Its labelling describes it as a treatment directed at amyloid beta, a protein that accumulates as plaques in the brain in Alzheimer’s disease, with the described aim of reducing those plaques.
Product Information
The following description reflects information associated with aducanumab and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the treatment of Alzheimer’s disease
- Described as targeting and reducing amyloid beta plaques in the brain
Described Dosage & Administration
- Administered only by a healthcare professional as an intravenous infusion
- Given at the interval set by the treating specialist; the course should be completed as prescribed
- An up-to-date medical history should be shared with the doctor before treatment
Described Side Effects
Commonly described side effects include:
- Amyloid-related imaging abnormalities (ARIA) — brain swelling or small bleeds seen on MRI, often without symptoms
- Headache
- Confusion, dizziness or visual changes
- Falls
- Infusion-related reactions
Any severe, persistent, or unexpected reaction requires prompt medical attention.
Precautions
- Periodic MRI monitoring is described in the labelling before and during treatment
- Symptoms such as headache, confusion, dizziness, nausea or visual disturbance should be reported promptly
- Use in people taking blood thinners is described as requiring caution
- Pregnancy or breastfeeding should be discussed with the prescriber
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains aducanumab and is described as reducing amyloid beta plaques in the brain in Alzheimer’s disease. SDO Pharma has not independently verified these claims and makes no claim of regulatory approval in any market unless independently confirmed.
Its labelling describes an intravenous infusion administered by a healthcare professional, with MRI scans before and during treatment.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.